Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Clinical and genetic study of neurofibromatosis type 1 in Croatia (CROSBI ID 510247)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Kapitanović, Helena ; Kapitanović, Sanja ; Čačev, Tamara ; Pavelić, Krešimir ; Sabol, Zlatko. Clinical and genetic study of neurofibromatosis type 1 in Croatia // European journal of human genetics / ICHG (ur.). 2001. str. 171-x

Podaci o odgovornosti

Kapitanović, Helena ; Kapitanović, Sanja ; Čačev, Tamara ; Pavelić, Krešimir ; Sabol, Zlatko.

engleski

Clinical and genetic study of neurofibromatosis type 1 in Croatia

Neurofibromatosis type 1 (NF1) is the common autosomal dominant disorder of humans appearing in childhood. Features defining the disease are multiple cafe-au-lait spots, multiple neurofibromas and Lisch nodules, but other features such as short stature, intellectual handicap, central-nervous tumors and other malignant diseases are also found. The gene NF1 was mapped to 17q11.2 and has been found to contain the mutations in NF1 patients. The mutation rate in the NF1 gene is one of the highest known for human genes with approximately 50% of all NF1 patients presenting as sporadic cases. Molecular analysis and genetic counseling is limited to the identification of the specific mutation in each patient or family or to the use of DNA polymorphisms and linkage analysis. We analysed 46 families with neurofibromatosis type 1. NF1 was diagnosed clinically according to the NIH criteria. A positive family history was found in 47.8% (22 of 46) and 52.2% (24 of 46) of affected patients were considered to be the result of a new mutation. DNA was obtained from peripheral blood of patients and related individuals. We used PCR-RFLP and VNTR analysis for linkage and LOH analysis in the affected families and individuals. Twenty-four families in Croatia population with the "de novo" mutation were studied using four intragenic markers. For VNTR analysis PCR products were separated on polyacrylamide gels or were analysed by submerged gel electrophoresis. LOH on the affected individual revealed a gross NF1 gene deletion in 3 (13.6%) families ; in 2 (67%) of them, the deletion was maternally and in one (33%) paternally derived.

NF1; LOH

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

171-x.

2001.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

European journal of human genetics

ICHG

Beč: Nature publishing group

1018-4813

Podaci o skupu

10th International Congress of Human Genetics

poster

10.05.2001-19.05.2001

Beč, Austrija

Povezanost rada

Temeljne medicinske znanosti

Indeksiranost